BIIB021 Free base
To Order Contact us: stephen@expresspharmapulse.com
 gel casting base for evs3300 |
|
EVS3300-BASE |
Consort |
ea |
EUR 301 |
) R406(free base) |
|
E1KS1533 |
EnoGene |
2mg |
EUR 521 |
) Xylazine (free base) |
|
Q-1445.0025 |
Bachem |
25.0g |
EUR 321 |
|
Description: Sum Formula: C12H16N2S; CAS# [7361-61-7] |
) R406 (free base) |
|
A5880-100 |
ApexBio |
100 mg |
EUR 1210 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-25 |
ApexBio |
25 mg |
EUR 514 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-5 |
ApexBio |
5 mg |
EUR 166 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 264 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
R406 (free base) |
|
A5880-S |
ApexBio |
Evaluation Sample |
EUR 81 |
|
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins. |
) Rucaparib (free base) |
|
A8893-10 |
ApexBio |
10 mg |
EUR 200 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-200 |
ApexBio |
200 mg |
EUR 1036 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-5 |
ApexBio |
5 mg |
EUR 137 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 142 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
Rucaparib (free base) |
|
A8893-50 |
ApexBio |
50 mg |
EUR 456 |
|
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway. |
 LY2835219 free base |
|
A3575-100 |
ApexBio |
100 mg |
EUR 572 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
LY2835219 free base |
|
A3575-25 |
ApexBio |
25 mg |
EUR 258 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
LY2835219 free base |
|
A3575-5 |
ApexBio |
5 mg |
EUR 142 |
|
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. |
) Ruxolitinib (free base) |
|
10-042 |
ProSci |
25 mg |
EUR 348.5 |
|
Description: Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19). |
) Apatinib (Free base) |
|
B1613-25 |
Biovision |
|
EUR 414 |
Apatinib (Free base) |
|
B1613-5 |
Biovision |
|
EUR 142 |
) Carubicin (Free base) |
|
B1853-1 |
Biovision |
|
EUR 153 |
Carubicin (Free base) |
|
B1853-5 |
Biovision |
|
EUR 457 |
 Anlotinib, free base |
|
B2156-25 |
Biovision |
|
EUR 588 |
Anlotinib, free base |
|
B2156-5 |
Biovision |
|
EUR 185 |
) Terbinafine (Free base) |
|
B2423-250 |
Biovision |
|
EUR 207 |
Terbinafine (Free base) |
|
B2423-50 |
Biovision |
|
EUR 120 |
) PLX5622 (free base) |
|
B2965-25 |
Biovision |
25 mg |
EUR 753 |
PLX5622 (free base) |
|
B2965-5 |
Biovision |
5 mg |
EUR 227 |
 Vatalanib, Free Base |
|
2026-25 |
Biovision |
|
EUR 305 |
Vatalanib, Free Base |
|
2026-5 |
Biovision |
|
EUR 126 |
 Erlotinib, Free Base |
|
2048-100 |
Biovision |
|
EUR 158 |
Erlotinib, Free Base |
|
2048-1000 |
Biovision |
|
EUR 387 |
 Sunitinib, Free base |
|
2097-100 |
Biovision |
|
EUR 191 |
Sunitinib, Free base |
|
2097-1000 |
Biovision |
|
EUR 501 |
Sunitinib, Free base |
|
2097-25 |
Biovision |
|
EUR 115 |
 Lapatinib, Free base |
|
2138-100 |
Biovision |
|
EUR 387 |
Lapatinib, Free base |
|
2138-25 |
Biovision |
|
EUR 191 |
 Ruxolitinib, Free base |
|
2139-100 |
Biovision |
|
Ask for price |
Ruxolitinib, Free base |
|
2139-25 |
Biovision |
|
EUR 533 |
Ruxolitinib, Free base |
|
2139-5 |
Biovision |
|
EUR 207 |
 Imatinib, Free base |
|
2141-100 |
Biovision |
|
EUR 147 |
Imatinib, Free base |
|
2141-1000 |
Biovision |
|
EUR 419 |
 Linsitinib, Free base |
|
2294-25 |
Biovision |
|
EUR 566 |
Linsitinib, Free base |
|
2294-5 |
Biovision |
|
EUR 185 |
 Tipifarnib, Free base |
|
2296-1 |
Biovision |
|
EUR 142 |
Tipifarnib, Free base |
|
2296-5 |
Biovision |
|
EUR 414 |
 BIIB021 |
|
A4058-10 |
ApexBio |
10 mg |
EUR 142 |
|
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone. |
BIIB021 |
|
A4058-100 |
ApexBio |
100 mg |
EUR 421 |
|
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone. |
BIIB021 |
|
A4058-5 |
ApexBio |
5 mg |
EUR 113 |
|
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone. |
BIIB021 |
|
A4058-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 121 |
|
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone. |
BIIB021 |
|
A4058-50 |
ApexBio |
50 mg |
EUR 293 |
|
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone. |
 Staurosporine, >99% Free Base |
|
BC090-001 |
GenDepot |
1mg |
EUR 246 |
Staurosporine, >99% Free Base |
|
BC090-005 |
GenDepot |
5mg |
EUR 340 |
 Vandetanib, >99% Free Base |
|
BC098-025 |
GenDepot |
25mg |
EUR 232 |
Vandetanib, >99% Free Base |
|
BC098-050 |
GenDepot |
50mg |
EUR 286 |
Vandetanib, >99% Free Base |
|
BC098-100 |
GenDepot |
100mg |
EUR 313 |
BIIB021 Free base
